Healthcare
MDxHealth SA, announced its business update and financial results for the year ended December 31, 2018 and provided its strategic outlook for 2019.
Vejthani Hospital in Bangkok announced the opening of a wound care center to offer comprehensive treatment for diabetic foot ulcers.
BioSpace gathered together a roundup of global biopharma news from the past week. Bayer and Orion Corporation, Themis Bioscience, Axonics Modulation Technologies, and more are mentioned in this edition.
Research is the cornerstone of new medications that treat numerous needs across the globe. Here’s a look at a few of the interesting research stories that crossed BioSpace’s slice of the Internet.
Medical technology company Admedus Ltd is pleased to advise that interim data from the animal study of its single-piece 3D aortic valve suggest that the device can be implanted safely and has the potential to deliver meaningful clinical benefits.
Lots of interesting biotech news from Asia, Europe and elsewhere was reported this week. From tapeworms to using a breathalyzer test in lung cancer diagnostics, the global biotech industry is exploding with ideas.
MDxHealth SA announced the appointment of Michael K. McGarrity to the position of Chief Executive Officer and member of the Board of Directors effective February 19, 2019.
Global healthcare spending is expected to increase dramatically to more than $10 trillion by 2022, driven primarily by an increase in spending on data that will increase value and create a sustainable culture.
Study was conducted on 36 kidney cancer patients using the CLEARScore™ test that identifies eight genes linked to immunotherapy
The hospital’s ASP has been designed to regulate the overuse of antibiotics
PRESS RELEASES